CN106633802A - Medical polymer material - Google Patents
Medical polymer material Download PDFInfo
- Publication number
- CN106633802A CN106633802A CN201611186887.3A CN201611186887A CN106633802A CN 106633802 A CN106633802 A CN 106633802A CN 201611186887 A CN201611186887 A CN 201611186887A CN 106633802 A CN106633802 A CN 106633802A
- Authority
- CN
- China
- Prior art keywords
- parts
- macromolecular materials
- medical macromolecular
- medical
- polymer material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
- C08L75/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/10—Transparent films; Clear coatings; Transparent materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/03—Polymer mixtures characterised by other features containing three or more polymers in a blend
- C08L2205/035—Polymer mixtures characterised by other features containing three or more polymers in a blend containing four or more polymers in a blend
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention relates to a medical polymer material. Specifically, the medical polymer material comprises the following components in parts by weight: 40 to 80 parts of thermoplastic polyurethane, 5 to 10 parts of methyl polymethacrylate, 2 to 5 parts of chitosan, 0.1 to 0.5 part of ascorbic acid, 1 to 3 parts of metallocene polyethylene, and 0.1 to 0.5 part of 2,4,6-tri(2',4'-dihydroxybenzyl)-1,3,5-triazine. The provided medical polymer material is transparent, can prevent the penetration of UV rays and visible light so as to protect drugs from light, has an antibacterial function, can prevent bacteria from entering a human body through the drugs, and does not contain any PVC. The medical polymer material will not generate any environmental pollution when being destroyed.
Description
Technical field
The invention belongs to field of functional materials, is related to a kind of medical macromolecular materials.
Background technology
Medical macromolecular materials refer to manufacture the polymerization of human body viscera, vitro in organ, pharmaceutical preparation and medical apparatus and instruments
Thing material, its source includes native biopolymer material and synthesising biological macromolecular material.Natural medical polymer materials come
Come from nature, including cellulose, chitin, hyaluronic acid, collagen protein, gelatin and sodium alginate etc.；Synthesis of medical macromolecule
Material passes through chemical method synthetic, including polyurethane, silicone rubber, polyester fiber, polyvinyl pyrrolidone, polyethers ether
Ketone, polymethyl methacrylate, polyvinyl alcohol, polylactic acid, polymethyl methacrylate etc..
At present, the improvement for conventional medical equipment in terms of material is not notable.Some existing transparent medical apparatus and instruments
Can usually cause photosensitizer recurring structure to change in use, so as to affect drug effect, or even some can be brought bad
Affect, but if using dark material, medical worker can be affected to observe again；Some existing medical apparatus and instruments are in use also
Antibacterial is brought in the medicine donor that poor mobile performance, portable antibacterial can be made, or even infection occurs；Existing medical material is high
Degree relies on PVC, and substantial amounts of discarded PVC can be all produced daily, not only causes very big burden to environment, and forces production cost
It is high.
The content of the invention
For above-mentioned situation, it is an object of the invention to provide a kind of water white transparency, anti-light, antibacterial, the doctor of energy-conserving and environment-protective
Use macromolecular material.
To achieve these goals, the present invention is employed the following technical solutions：
A kind of medical macromolecular materials, it includes the following component in terms of parts by weight：Thermoplastic polyurethane (TPU) 40～
80 parts, 5～10 parts of polymethyl methacrylate, 2～5 parts of shitosan, 0.1～0.5 part of ascorbic acid, metallocene PE 1～3
0.1～0.5 part of part and (2 ', 4 '-dihydroxy phenyl) -1,3,5- of 2,4,6- tri- triazines.
Preferably, above-mentioned medical macromolecular materials include the following component in terms of parts by weight：Thermoplastic polyurethane 50～
70 parts, 6～9 parts of polymethyl methacrylate, 3～4 parts of shitosan, 0.2～0.4 part of ascorbic acid, metallocene PE 1～2
0.2～0.4 part of part and (2 ', 4 '-dihydroxy phenyl) -1,3,5- of 2,4,6- tri- triazines.
It is furthermore preferred that above-mentioned medical macromolecular materials include the following component in terms of parts by weight：Thermoplastic polyurethane 60
Part, 8 parts of polymethyl methacrylate, 4 parts of shitosan, 0.3 part of ascorbic acid, 2 parts and 2,4,6- tri- of metallocene PE (2 ',
4 '-dihydroxy phenyl) 0.3 part of -1,3,5- triazines.
Preferably, in above-mentioned medical macromolecular materials, the vitrification point of the thermoplastic polyurethane is 100～106
DEG C, hard segment content is 30～36%.
Preferably, in above-mentioned medical macromolecular materials, the number-average molecular weight of the polymethyl methacrylate is 80000
～100000.
Preferably, in above-mentioned medical macromolecular materials, the deacetylation of the shitosan is 70～95%.
Compared with prior art, there is advantages below using the present invention of above-mentioned technical proposal：
1st, the combination of " thermoplastic polyurethane+polymethyl methacrylate " causes medical macromolecular materials of the invention not only
With the transparency, and ultraviolet and visible ray can be intercepted material is penetrated, it is to avoid light produces impact to medicine；
2nd, shitosan has antibacterial characteristics, and mixing in material can effectively suppress antibacterial to enter human body by medicine；
3rd, PVC compositions are entirely free of in medical macromolecular materials of the invention, and use metallocene PE instead, be conducive to
Environmental pollution is reduced when destroying medical material.
Specific embodiment
Technical scheme is further illustrated below in conjunction with specific embodiment.It should be noted that these realities
Apply example and be only used for explaining the present invention, and and never in any form limiting the present invention.
Embodiment 1：The preparation of medical macromolecular materials.
The medical macromolecular materials of the present embodiment include following component：Thermoplastic polyurethane (vitrification point be 100～
106 DEG C, hard segment content is 30～36%) 40kg, polymethyl methacrylate (number-average molecular weight 80000) 5kg, shitosan are (de-
Acetyl degree is 70%) 2kg, ascorbic acid 0.1kg, (2 ', 4 '-dihydroxy phenyl) -1 of metallocene PE 1kg and 2,4,6- tri-,
3,5- triazines 0.1kg.
Embodiment 2：The preparation of medical macromolecular materials.
The medical macromolecular materials of the present embodiment include following component：Thermoplastic polyurethane (vitrification point be 100～
106 DEG C, hard segment content is 30～36%) 80kg, polymethyl methacrylate (number-average molecular weight 100000) 10kg, shitosan
(deacetylation is 95%) 5kg, ascorbic acid 0.5kg, (2 ', the 4 '-dihydroxy benzenes of metallocene PE 3kg and 2,4,6- tri-
Base) -1,3,5- triazines 0.5kg.
Embodiment 3：The preparation of medical macromolecular materials.
The medical macromolecular materials of the present embodiment include following component：Thermoplastic polyurethane (vitrification point be 100～
106 DEG C, hard segment content is 30～36%) 50kg, polymethyl methacrylate (number-average molecular weight 80000) 6kg, shitosan are (de-
Acetyl degree is 80%) 3kg, ascorbic acid 0.2kg, (2 ', 4 '-dihydroxy phenyl) -1 of metallocene PE 1kg and 2,4,6- tri-,
3,5- triazines 0.2kg.
Embodiment 4：The preparation of medical macromolecular materials.
The medical macromolecular materials of the present embodiment include following component：Thermoplastic polyurethane (vitrification point be 100～
106 DEG C, hard segment content is 30～36%) 60kg, polymethyl methacrylate (number-average molecular weight 90000) 8kg, shitosan are (de-
Acetyl degree is 90%) 4kg, ascorbic acid 0.3kg, (2 ', 4 '-dihydroxy phenyl) -1 of metallocene PE 2kg and 2,4,6- tri-,
3,5- triazines 0.3kg.
Claims (6)
1. a kind of medical macromolecular materials, it includes the following component in terms of parts by weight：It is 40～80 parts of thermoplastic polyurethane, poly-
5～10 parts of methyl methacrylate, 2～5 parts of shitosan, 0.1～0.5 part of ascorbic acid, 1～3 part of metallocene PE and 2,
0.1～0.5 part of (2 ', 4 '-dihydroxy phenyl) -1,3,5- of 4,6- tri- triazines.
2. medical macromolecular materials according to claim 1, it is characterised in that the medical macromolecular materials are included with weight
The following component of amount number meter：50～70 parts of thermoplastic polyurethane, 6～9 parts of polymethyl methacrylate, 3～4 parts of shitosan,
0.2～0.4 part of ascorbic acid, 1～2 part and 2,4,6- tri- (2 ', 4 '-dihydroxy phenyl) -1,3,5- triazine of metallocene PE
0.2～0.4 part.
3. medical macromolecular materials according to claim 2, it is characterised in that the medical macromolecular materials are included with weight
The following component of amount number meter：60 parts of thermoplastic polyurethane, 8 parts of polymethyl methacrylate, 4 parts of shitosan, ascorbic acid 0.3
Part, 2 parts and 2,4,6- tri- 0.3 part of (2 ', 4 '-dihydroxy phenyl) -1,3,5- triazines of metallocene PE.
4. medical macromolecular materials according to any one of claim 1 to 3, it is characterised in that the thermoplastic poly ammonia
The vitrification point of ester is 100～106 DEG C, and hard segment content is 30～36%.
5. medical macromolecular materials according to any one of claim 1 to 3, it is characterised in that the polymethyl
The number-average molecular weight of sour methyl ester is 80000～100000.
6. medical macromolecular materials according to any one of claim 1 to 3, it is characterised in that the shitosan it is de-
Acetyl degree is 70～95%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611186887.3A CN106633802A (en) | 2016-12-20 | 2016-12-20 | Medical polymer material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611186887.3A CN106633802A (en) | 2016-12-20 | 2016-12-20 | Medical polymer material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106633802A true CN106633802A (en) | 2017-05-10 |
Family
ID=58834278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611186887.3A Pending CN106633802A (en) | 2016-12-20 | 2016-12-20 | Medical polymer material |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106633802A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107383617A (en) * | 2017-08-29 | 2017-11-24 | 南通成山高分子材料有限公司 | A kind of new medical high polymer material |
| CN107446238A (en) * | 2017-08-29 | 2017-12-08 | 南通成山高分子材料有限公司 | A kind of preparation method of new medical high polymer material |
| CN107446214A (en) * | 2017-08-29 | 2017-12-08 | 南通成山高分子材料有限公司 | A kind of preparation method of medical macromolecular materials |
| CN107474362A (en) * | 2017-08-29 | 2017-12-15 | 南通成山高分子材料有限公司 | A kind of medical macromolecular materials |
| CN108659512A (en) * | 2018-05-24 | 2018-10-16 | 东莞市联洲知识产权运营管理有限公司 | A kind of new medical anti-microbial catheter and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101333282A (en) * | 2007-06-25 | 2008-12-31 | 财团法人工业技术研究院 | Water proof and moisture permeable material, thin film and fabric |
| CN102125704A (en) * | 2010-09-16 | 2011-07-20 | 刘昊仁 | Novel macromolecular polymer medical splint |
| CN104174072A (en) * | 2014-08-07 | 2014-12-03 | 西安科技大学 | Medical polyurethane pancreaticojejunostomy device material and preparation method thereof |
-
2016
- 2016-12-20 CN CN201611186887.3A patent/CN106633802A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101333282A (en) * | 2007-06-25 | 2008-12-31 | 财团法人工业技术研究院 | Water proof and moisture permeable material, thin film and fabric |
| CN102125704A (en) * | 2010-09-16 | 2011-07-20 | 刘昊仁 | Novel macromolecular polymer medical splint |
| CN104174072A (en) * | 2014-08-07 | 2014-12-03 | 西安科技大学 | Medical polyurethane pancreaticojejunostomy device material and preparation method thereof |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107383617A (en) * | 2017-08-29 | 2017-11-24 | 南通成山高分子材料有限公司 | A kind of new medical high polymer material |
| CN107446238A (en) * | 2017-08-29 | 2017-12-08 | 南通成山高分子材料有限公司 | A kind of preparation method of new medical high polymer material |
| CN107446214A (en) * | 2017-08-29 | 2017-12-08 | 南通成山高分子材料有限公司 | A kind of preparation method of medical macromolecular materials |
| CN107474362A (en) * | 2017-08-29 | 2017-12-15 | 南通成山高分子材料有限公司 | A kind of medical macromolecular materials |
| CN108659512A (en) * | 2018-05-24 | 2018-10-16 | 东莞市联洲知识产权运营管理有限公司 | A kind of new medical anti-microbial catheter and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106633802A (en) | Medical polymer material | |
| Szymańska et al. | Stability of chitosan—a challenge for pharmaceutical and biomedical applications | |
| Cardoso et al. | Marine origin polysaccharides in drug delivery systems | |
| Gomez d’Ayala et al. | Marine derived polysaccharides for biomedical applications: chemical modification approaches | |
| Oh et al. | Characterization of an oxidized alginate-gelatin hydrogel incorporating a COS-salicylic acid conjugate for wound healing | |
| Szabó et al. | Strategies to functionalize the anionic biopolymer Na-alginate without restricting its polyelectrolyte properties | |
| Lu et al. | Development of injectable fucoidan and biological macromolecules hybrid hydrogels for intra-articular delivery of platelet-rich plasma | |
| Mamidi et al. | Covalently functionalized carbon nano-onions integrated gelatin methacryloyl nanocomposite hydrogel containing γ-cyclodextrin as drug carrier for high-performance pH-triggered drug release | |
| Serrano-Aroca et al. | Antiviral properties of alginate-based biomaterials: promising antiviral agents against SARS-CoV-2 | |
| Khan et al. | Antibacterial and hemocompatible pH-responsive hydrogel for skin wound healing application: In vitro drug release | |
| Yuan et al. | Fabrication of injectable chitosan-chondroitin sulfate hydrogel embedding kartogenin-loaded microspheres as an ultrasound-triggered drug delivery system for cartilage tissue engineering | |
| Al-Arjan et al. | pH-Responsive PVA/BC-f-GO dressing materials for burn and chronic wound healing with curcumin release kinetics | |
| Chen et al. | Electrospun water-borne polyurethane nanofibrous membrane as a barrier for preventing postoperative peritendinous adhesion | |
| Spiridon et al. | Development and performance of bioactive compounds-loaded cellulose/collagen/polyurethane materials | |
| Schenk et al. | RGD-functionalization of poly (2-oxazoline)-based networks for enhanced adhesion to cancer cells | |
| Vigani et al. | Dual-functioning scaffolds for the treatment of spinal cord injury: alginate nanofibers loaded with the sigma 1 receptor (S1R) agonist RC-33 in chitosan films | |
| Correia et al. | Adhesive and biodegradable membranes made of sustainable catechol-functionalized marine collagen and chitosan | |
| Bernal-Ballen et al. | (PVA/chitosan/fucoidan)-ampicillin: a bioartificial polymeric material with combined properties in cell regeneration and potential antibacterial features | |
| Fonseca et al. | Antibacterial multi-layered nanocellulose-based patches loaded with dexpanthenol for wound healing applications | |
| Szulc et al. | Biomaterials based on chitosan and its derivatives and their potential in tissue engineering and other biomedical applications—A review | |
| Ren et al. | Injectable and antioxidative HT/QGA hydrogel for potential application in wound healing | |
| Andrade del Olmo et al. | Drug delivery from hyaluronic Acid–BDDE injectable hydrogels for antibacterial and anti-inflammatory applications | |
| Zamora-Mendoza et al. | Antimicrobial properties of plant fibers | |
| Kłosiński et al. | Biocompatibility and mechanical properties of carboxymethyl chitosan hydrogels | |
| Zapata et al. | Osseointegration of antimicrobial acrylic bone cements modified with graphene oxide and chitosan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |
|
| RJ01 | Rejection of invention patent application after publication |